Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [4]
Submit
Validation data
Reference
Comment
Report error
- Product number
- NBP1-86157 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#NBP1-86157, RRID:AB_11029494
- Product name
- Rabbit Polyclonal ASB7 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified. Specificity of human ASB7 antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.1 ml
- Storage
- Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: ASB7 Antibody [NBP1-86157] - Analysis in control (vector only transfected HEK293T lysate) and aSB7 over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (3.1 kDa) in mammalian HEK293T cells).
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: ASB7 Antibody [NBP1-86157] - Staining of human urinary bladder shows moderate cytoplasmic positivity in urothelial cells.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: ASB7 Antibody [NBP1-86157] - Staining of human pancreas shows low expression as expected.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: ASB7 Antibody [NBP1-86157] - Staining of human testis shows high expression.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Immunohistochemistry-Paraffin: ASB7 Antibody [NBP1-86157] - Staining in human testis and pancreas tissues using anti-ASB7 antibody. Corresponding ASB7 RNA-seq data are presented for the same tissues.